Module 557

General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets:	6
Num genes:	11 (see 460 additional genes for this module)
Num experiments:	94 (34 induced, 60 repressed)
Parent module:	None
Children modules:	470

Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
lipoprotein binding
Glycerolipid_metabolism
amine oxidase activity
GPCRs, Class B Secretin_like
secretin_like receptor activity
Staunton01 16

Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation	Category	P-value	Hits	Hits(%)	Module hits in category	Arrays in annotation	Arrays
Acute leukemia (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Cancer and cell line (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Cancer (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Hematologic cancer and cell line (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Hematologic cancer (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Hematologic samples and cell lines (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Leukemia (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Leukemia or leukemia cell line (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Monocytes (Leukemia*)	Leukemia*	2.1e-15	26	43.3	60	141	1945
Diffuse large B cell lymphoma - DLBCL (Various tumors)	Various tumors	5.1e-07	8	47.0	17	11	154
Diffuse large B cell lymphoma tumor or cell line (Various tumors)	Various tumors	5.1e-07	8	47.0	17	11	154
Cancer and cell line (Various tumors*)	Various tumors*	1.6e-06	14	23.3	60	105	1945
Cancer (Various tumors*)	Various tumors*	1.6e-06	14	23.3	60	105	1945
B cells (Various tumors)	Various tumors	7.8e-06	10	58.8	17	23	154
Lymphoma (Various tumors)	Various tumors	2.1e-05	9	52.9	17	20	154
Normal lung tissue (Lung cancer)	Lung cancer	4.5e-05	6	54.5	11	22	276
Normal tissue (Lung cancer)	Lung cancer	6.0e-05	6	54.5	11	23	276
Lymphocytes (Various tumors)	Various tumors	7.0e-05	10	58.8	17	28	154
Monocytes (Various tumors)	Various tumors	7.0e-05	10	58.8	17	28	154
Hematologic samples and cell lines (Various tumors)	Various tumors	0.0001	11	64.7	17	37	154
Hematologic samples (Various tumors)	Various tumors	0.0001	11	64.7	17	37	154
Hematologic cancer and cell line (Various tumors)	Various tumors	0.0002	10	58.8	17	31	154
Hematologic cancer (Various tumors)	Various tumors	0.0002	10	58.8	17	31	154
Primary blood mononuclear cells (Various tumors)	Various tumors	0.0002	10	58.8	17	31	154

Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation	P-value	Hits	Hits(%)	Module genes	Genes in annotation	Genes
amine oxidase activity	5.2e-08	3	33.3	9	5	4566
oxidoreductase activity\, acting on the CH-NH2 group of donors\, oxygen as acceptor	2.9e-07	3	33.3	9	8	4566
oxidoreductase activity\, acting on the CH-NH2 group of donors	4.4e-07	3	33.3	9	9	4566

Visual display

Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.

You can also view the images within GeneXPress by loading the module gxp file file.

>4x